• Home
  • About
  • Book
  • Speaking
  • Views/Blog
  • Contact

WSJ: U.S. Drug Spending Climb

Posted April 15, 2016 by Karen Firestone

By PETER LOFTUS
April 14, 2016 12:01 a.m. ET

The new Hepatitis C drugs are accounting for much of this increase.  Will it be worth it to have brought such headline risk to the industry?

Read the full article in The Wall Street Journal

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Google
  • Email
filed under: Finance, General, Investing

GET IN TOUCH

Contact Karen Firestone >

Karen Firestone

© Copyright 2018 Karen on Even the Odds. All Rights Reserved. Site by Rose Srebro Design and Truly Good Design
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.